What is MBX Biosciences, Inc.'s price / book?

MBX Biosciences, Inc. (MBX) reported price / book of 3.2× in Q1 2026.

How has MBX Biosciences, Inc.'s price / book changed year-over-year?

MBX Biosciences, Inc.'s price / book increased by 209.2% year-over-year, from 1× to 3.2×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

MBX Biosciences, Inc. MBX Price / book

Price / book at other companies

Eli LillyLLY

26.3×-20.7×

AmgenAMGN

20.6×-6.3×

Viking TherapeuticsVKTX

7.5×+4.3×

Amylyx Pharmaceuticals, Inc.AMLX

5.6×+4.1×

Nurix Therapeutics, Inc.NRIX

3.4×+1.0×

Crinetics PharmaceuticalsCRNX

3×+0.5×

Other financials

Income statement

See full

Operating income-$27.3M-2.8%

Net income-$23.5M+1.5%

EPS (diluted)-$0.50+29.6%

Balance sheet

See full

Cash & equivalents$45.2M+51.2%

Total debt$555.0K+327%

Total equity$437.8M+85.9%

Total assets$452.7M+84.1%

Cash flow

See full

Operating cash flow-$20.2M+10.9%

CapEx$437.0K+1,357%

Free cash flow-$20.6M+9.1%

Valuation

See full

Market cap$2.21B+475%

Enterprise value$2.16B+533%

Returns & leverage

See full

Return on equity-25.7%—

Debt / equity0×0.0×

Current ratio30.8×+7.5×

Where this comes from

Calculated from MBX Biosciences, Inc.’s reported figures.

market cap/total stockholders equity=3.2×

Based on the most recent quarter.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MBX Biosciences, Inc.'s price / book?: MBX Biosciences, Inc. (MBX) reported price / book of 3.2× in Q1 2026.
How has MBX Biosciences, Inc.'s price / book changed year-over-year?: MBX Biosciences, Inc.'s price / book increased by 209.2% year-over-year, from 1× to 3.2×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.